The existing body of research involving rats exposed to BPC-157 suggests that the BPC-157 peptide may exhibit healing and anti-inflammatory impacts. By the end of this article, we will provide you with a digest on the speculated properties of BPC-157 peptide according to existing research.
BPC-157 Peptide: What is it?
BPC-157, also known as pentadecapeptide, is classified as a body protection compound. The sequence of 15 amino acids is arranged in a unique pattern that does not occur naturally, according to a study published in a scientific journal.
It is created in labs by synthesizing a partial sequence of the compounds found in gastric juices, which help protect cells; therefore, it is a derivative of the peptide in gastric juices.
BPC-157 Peptide: Mechanism of Action
Studies suggest that the potential of BPC-157 peptides may be achieved through various mechanisms. BPC-157 is frequently utilized as an agent in research studies because it has been hypothesized to facilitate angiogenesis, generating new blood vessels.
Research suggests that it may accomplish this by triggering a protein known as the “vascular endothelial growth factor,” which kickstarts the development of fresh blood vessels. This is purported to result in the forming of a robust vascular network responsible for the potentially regenerative and healing possibilities of BPC-157.
BPC-157 has been speculated to block the inhibitory growth factor known as 4-hydroxynonenal, which plays a role in regulating growth. The peptide is proposed to enable efficient wound healing, particularly near tendons.
Additionally, it has been theorized to stimulate the tendon cells to increase the production of receptors that can attach to molecules responsible for growth signaling. The objective of this is to accelerate the process of growth and repair.
Findings imply that BPC-157 may enhance the proliferation of fibroblasts. Fibroblasts are crucial in synthesizing collagen, a vital and widely present structural protein.
BPC-157 has been scientifically theorized to affect the functioning of neurotransmitters located in the brain. Neurotransmitters like serotonin, dopamine, and GABA are believed to be impacted by the activity of BPC-157.
This peptide is well-documented for its potential to stimulate the production of nitric oxide (NO), leading to the dilation of endothelial cells. As a result, there may be a decrease in overall blood pressure. Investigations purport that it may also aid in addressing conditions such as hyperkalemia, which refers to elevated potassium levels.
BPC-157 Peptide Potential
Although the absence of extensive trials raises questions about the working research hypotheses presented for this peptide, it is possible to draw connections between some of the significant attributes of BPC-157 based on studies conducted on rats.
BPC-157 is derived from gastric juices, indicating the primary area where it may exert its most potent healing potential.
BPC-157 suggests encouraging outcomes in the context of stomach ulcers. Based on studies conducted on rats, this pentadecapeptide has been scientifically hypothesized to effectively aid gastrointestinal fistula abnormalities in the digestive tract.
Several studies have also provided speculation on the effectiveness of BPC-157 in the context of inflammatory bowel diseases (IBD) and reducing inflammation at wound sites.
Extensive experimental research conducted on rats has purported the remarkable potential of BPC-157 in the context of Achilles tendon injuries and muscle healing. This potential is speculated to be achieved through the fascinating process of angiogenesis.
Scientists suggest that BPC-157 may impact the growth rates of bones, tendons, and joints by enhancing the receptors for growth hormones.
This compound has also been speculated to enhance the healing process of skin damaged by burns. Additionally, skin with multiple cuts appeared to recover quickly when presented with BPC-157 peptide. Studies suggest that when damaged, bone may regenerate after being presented with the appropriate amount of BPC-157. Researchers hypothesize this may happen due to an increase in fibroblast growth.
Research suggests that by potentially having an impact on the brain and cognitive functions, BPC-157 may aid in regenerating nerve cells. This potentially facilitates the reduction of cognitive decline over time.
Interestingly, experiments conducted on rats that were poisoned with NSAIDs suggested a reversal in toxic effects when they were presented with BPC-157. As a result, BPC-157 has been hypothesized to have the potential to be used in research models for counteracting toxicity in organs such as the liver and kidney. Lastly, BPC-157 is considered to have pain-relieving properties, as it has been suggested to reduce the intensity of pain symptoms.
Scientists interested in further studying this compound may buy it from Biotech Peptides and other high-quality research material. Please note that the substances mentioned in this paper are not recommended for human use or outside confined environments such as laboratories. Only licensed professionals are encouraged to acquire these peptides.
References
[i] Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80. doi: 10.1152/japplphysiol.00945.2010. Epub 2010 Oct 28. PMID: 21030672.
[ii] Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009 Dec;60 Suppl 7:191-6. PMID: 20388964.
[iii] Jelovac N, Sikiric P, Rucman R, Petek M, Perovic D, Marovic A, Anic T, Seiwerth S, Mise S, Pigac B, Duplancie B, Turkovic B, Dodig G, Prkacin I, Stancic-Rokotov D, Zoricic I, Aralica G, Sebecic B, Ziger T, Slobodnjak Z. The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam. Chin J Physiol. 1999 Sep 30;42(3):171-9. PMID: 10707891.
[iv] Sikirić P, Seiwerth S, Grabarević Z, Rucman R, Petek M, Jagić V, Turković B, Rotkvić I, Mise S, Zoricić I, Konjevoda P, Perović D, Jurina L, Separović J, Hanzevacki M, Artuković B, Bratulić M, Tisljar M, Gjurasin M, Miklić P, Stancić-Rokotov D, Slobodnjak Z, Jelovac N, Marović A. The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure. Eur J Pharmacol. 1997 Jul 30;332(1):23-33. doi: 10.1016/s0014-2999(97)01033-9. PMID: 9298922.
[v] Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M, Klicek R, Radic B, Drmic D, Ilic S, Kolenc D, Aralica G, Safic H, Suran J, Rak D, Dzidic S, Vrcic H, Sebecic B. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2013;19(1):76-83. doi: 10.2174/13816128130111. PMID: 22950504.
[vi] Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Konjevoda P, Perovic D, Simicevic V, Separovic J, Hanzevacki M, Ljubanovic D, Artukovic B, Bratulic M, Tisljar M, Rekic B, Gjurasin M, Miklic P, Buljat G. Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats. J Physiol Paris. 1997 May-Oct;91(3-5):113-22. doi: 10.1016/s0928-4257(97)89474-0. PMID: 9403784.